Oncology In Vitro Research Platform:
Our oncology in vitro research platform is specifically designed for drug screening and efficacy evaluation, offering a suite of advanced techniques and experimental methods to simulate and evaluate the effects of drugs on tumor cells in an in vitro environment.

Platform Features:
• PDC High-throughput In Vitro Pharmacodynamics: Rapid in vitro drug efficacy evaluations using high-throughput techniques.
• 3D Organoids: Mimic a genuine biological microenvironment, providing a closer-to-in vivo assessment environment for drugs.
• IC50: Precisely measures the half-maximal inhibitory concentration of drugs on cell growth.
Tumor Immunology In Vitro Research Platform (Co-culture Cytotoxicity Model):
Our tumor immunology in vitro research platform focuses on simulating and evaluating the effects of immune cells on tumor cells in vitro, providing key insights for immunotherapy strategies.

Platform Features:
• CDC: Evaluates the complement-dependent cytotoxicity induced by drugs.
• ADCC: Measures antibody-dependent cell-mediated cytotoxicity induced by drugs.
• T-cell Mediated Cytotoxicity Experiment: Provides in-depth evaluations of T-cell cytotoxicity against tumor cells.
Our in vitro research platforms combine a variety of cutting-edge techniques, dedicated to providing comprehensive support for your tumor and tumor immunotherapy research. Should you have any questions or require further insights, please don't hesitate to contact us.